Mineralys Therapeutics (MLYS) Earnings Date & Reports

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLYS is expected to report earnings to rise 459.57% to -263 cents per share on August 18

Mineralys Therapeutics MLYS Stock Earnings Reports

Q2'26

Est.

$-2.63

Q1'26

Beat

by $0.34

Q4'25

Beat

by $0.54

Q3'25

Beat

by $0.44

Q2'25

Beat

by $0.40

The last earnings report on May 06 showed earnings per share of -46 cents, beating the estimate of -81 cents. With 8.17M shares outstanding, the current market capitalization sits at 2.38B.

View a ticker or compare two or three

Compare

MLYS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MLYS